Folic acid, B vitamins not linked to reduced risk of cardiovascular events in high-risk women

Women at high-risk of cardiovascular disease who took a daily supplement of folic acid and vitamin B6 and B12 for seven years did not have an overall reduced rate of cardiovascular events, despite a significant lowering of homocysteine levels, according to a study in the May 7 issue of JAMA.

“Homocysteine [an amino acid produced by the body] levels have been directly associated with cardiovascular risk in observational studies; and daily supplementation with folic acid, vitamin B6, vitamin B12, or a combination have been shown to reduce homocysteine levels to varying degrees in intervention studies,” the authors write.

Observational data suggest cardiovascular benefits from B-vitamin supplementation may be greater among women, yet women have been underrepresented in published randomized trials. “Given the paucity of data on women and the known influences of estrogen on homocysteine levels, adequately powered randomized trials of homocysteine lowering in women are still needed.”

Christine M. Albert, M.D., M.P.H., of Brigham and Women’s Hospital and Harvard Medical School, Boston, and colleagues tested whether a combination of folic acid, vitamin B6 and vitamin B12 would reduce total cardiovascular events among women at high risk for the development of cardiovascular disease (CVD) over 7 years of follow-up. Within an ongoing randomized trial of antioxidant vitamins, 5,442 women who were U.S. health professionals age 42 years or older, with either a history of CVD or three or more coronary risk factors, were enrolled in a randomized trial to receive a combination pill containing folic acid (2.5 mg), vitamin B6 (50 mg), and vitamin B12 (1 mg) or a matching placebo.

During the 7.3 years of follow-up, 796 participants (14.6 percent) experienced a confirmed CVD event included in the primary end point (heart attack, stroke, coronary revascularization, or CVD death), with some individuals experiencing more than one event. There was no difference in the cumulative incidence of the primary combined end point in the active vs. placebo treatment groups at any time during study follow-up. A total of 406 women (14.9 percent) in the active treatment group and 390 (14.3 percent) in the placebo group experienced at least one cardiovascular event included in the primary end point.

When analyzed separately, there were no significant differences for each of the components of the primary outcome including heart attack, stroke, and CVD death, between the active treatment and placebo groups. Also, the risk of death from any cause was similar between the active and placebo treatment groups.

The researchers also found that the average plasma homocysteine level was 18.5 percent lower in the active group than that observed in the placebo group.

“Our results are consistent with prior randomized trials performed primarily among men with established vascular disease and do not support the use of folic acid and B vitamin supplements as preventive interventions for CVD in these high-risk fortified populations,” the authors write.

Citation: JAMA. 2008;299[17]:2027-2036.

Source: JAMA and Archives Journals

Related stories:

Get a Little Sun This Summer – It Could Help Save Your Life
As summer comes and people across America get ready to start slathering on the sunscreen, a note of caution is in order – a little sunshine is good for you.
Regular low dose aspirin cuts asthma risk in women
A small dose of aspirin on alternate days can cut the risk of developing asthma among women, suggests a large study, published ahead of print in Thorax.
Certain vitamin supplements may increase lung cancer risk, especially in smokers
Vitamin supplements do not protect against lung cancer, according to a study of more than 77,000 vitamin users. In fact, some supplements may even increase the risk of developing it.
Drinking milk may help ease the pressure
Women who drank more fat free milk and had higher intakes of calcium and vitamin D from foods, and not supplements, tended to have a lower risk for developing hypertension or high blood pressure, according to a new study published in the American Heart Association journal, Hypertension.
4 health behaviors can add 14 extra years of life
People who adopt four healthy behaviours – not smoking; taking exercise; moderate alcohol intake; and eating five servings of fruit and vegetables a day – live on average an additional fourteen years of life compared with people who adopt none of these behaviours, according to a study published in the open access journal PLoS Medicine.
Message to the elderly: It's never too late to prevent illness
A new study by a NewYork-Presbyterian Hospital/Weill Cornell Medical Center physician-scientist has an important message for the elderly: It's not too late to improve your health through diet and exercise, even if you've had an unhealthy lifestyle in the past!
Impact of elevated homocysteine levels on vision under study
Homocysteine, an amino acid believed to contribute to heart attack, stroke and dementia, likely also is a player in retinal damage and vision loss, researchers say.
Antioxidants show no clear benefit against cardiovascular events, death in high-risk women
Vitamins C and E and beta carotene, either individually or in combination, do not appear to reduce the risk of cardiovascular events or death among women at high risk for heart disease, according to a report in the August 13/27 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

News discussion:

Medicine & Health news